Reduced medial temporal lobe <i>N</i> -acetylaspartate in cognitively impaired but nondemented patients

Abstract

Reduced medial temporal lobe N-acetylaspartate, together with reduced hippocampal and neocortical gray matter volumes, may be early indications of dementia-related pathology in subjects at high risk for developing dementia.